SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India reports 8% rise in Q4 consolidated net profit

15 May 2024 Evaluate

Granules India has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 22.40% fall in its net profit at Rs 97.22 crore for the quarter under review as compared to Rs 125.29 crore for the same quarter in the previous year. Total income of the company decreased by 7.16% at Rs 943.62 crore for Q4FY24 as compared Rs 1,016.44 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 8.39% rise in its net profit at Rs 129.65 crore for fourth quarter ended March 31, 2024 as compared to Rs 119.61 crore for the same quarter in the previous year. However, total income of the company decreased by 1.77% at Rs 1,177.65 crore for Q4FY24 as compared Rs 1,198.88 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 12.60% fall in its net profit at Rs 435.92 crore as compared to Rs 498.79 crore for the previous year. Total income of the company decreased by 4.57% at Rs 3,760.87 crore for year under review as compared to Rs 3,941.13 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 21.54% fall in its net profit at Rs 405.31 crore as compared to Rs 516.60 crore for the previous year. Total income of the company decreased by 0.33% at Rs 4,510.77 crore for year under review as compared to Rs 4,525.70 crore for year ended March 31, 2023.


Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×